Completed PHASE3 INTERVENTIONAL 2-arm NCT00314028

Effectiveness of HIV Risk Reduction Program Among African American Men

Promoting HIV Risk Reduction Among African American Men

Sponsor: National Institute of Mental Health (NIMH)

Conditions HIV Sexually Transmitted Diseases

Interventions Control standard of care treatment Focus on the Future

Updated 5 times since 2017 Last updated: Dec 13, 2013 Started: Apr 30, 2003 Primary completion: Sep 30, 2007 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates HIV and Sexually Transmitted Diseases and is currently completed. National Institute of Mental Health (NIMH) leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
Richard Crosby

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.